Navigation Links
Biopure Operations Compliant With U.K. Manufacturing Guidelines
Date:4/11/2008

CAMBRIDGE, Mass., April 11 /PRNewswire-FirstCall/ -- Biopure Corporation (Nasdaq: BPUR) announced today that the United Kingdom's Medicines and Healthcare products Regulatory Agency (MHRA) has found the company's Pennsylvania manufacturing facility to be in general compliance with the principles and guidelines of good manufacturing practices as identified in the Commission Directives. The company received confirmation that it has responded successfully to the issues classified as "Other" in the MHRA's original inspection letter. The original inspection report contained no "Critical" or "Major" deficiencies.

As previously announced, Biopure has been invited by the MHRA to meet with the MHRA team of reviewers to discuss issues still outstanding from the application for registration of Hemopure for use in the treatment of acute anemia following orthopedic surgery blood loss when blood is not readily available or not an option. The company intends to announce the date of this meeting when it is set, as well as the outcome of the meeting and an anticipated timeline for the resolution of issues.

Biopure Corporation

Biopure Corporation develops, manufactures and markets pharmaceuticals, called oxygen therapeutics, that are intravenously administered to deliver oxygen to the body's tissues. Hemopure(R) [hemoglobin glutamer - 250 (bovine)], or HBOC-201, is approved for sale in South Africa for the treatment of surgical patients who are acutely anemic. The company is developing Hemopure for other indications and is supporting the U.S. Navy's government- funded efforts to develop a potential out-of-hospital trauma indication. Biopure's veterinary product Oxyglobin(R)[hemoglobin glutamer - 200 (bovine)], or HBOC-301, the only oxy
'/>"/>

SOURCE Biopure Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Biopure Appoints New Independent Auditor
2. Biopure Completes U.K. Regulatory Agency Inspection
3. Biopure Announces 2008 First Quarter Financial Results
4. Biopure Launches Updated Website
5. Biopure Announces Pricing of Equity Offering
6. Biopure Gives Update on Malaysia Joint Venture Discussions
7. Genta Restructures Operations to Focus on Priority Initiatives
8. NxStage Appoints Tom Shea as Senior Vice President of Manufacturing Operations
9. NanoLogix Inc. Presents at the National Hydrogen Association Conference & Provides Operations, Management and Director Update
10. Mentice AB Announces Leadership Changes Within Its Worldwide Operations
11. Michael J. Simms Joins Alexza Pharmaceuticals as Senior Vice President, Operations and Manufacturing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... SAN MARINO, Calif., Dec. 15 Epeius ... of targeted genetic medicine, gained international validation of ... Rexin-G , when scientists around the world ... be a major locus of cancer pathogenesis and ... anti-cancer therapies. Recently, scientists at the NIH National ...
(Date:12/15/2009)... Reportlinker.com announces that a new ... catalogue: ,, The Future of ... 2015, Pipeline Analysis and Reimbursement ... ,, Summary ,, The author ... of Orphan Diseases Therapeutics - Market Forecasts ...
(Date:12/15/2009)... 15 The Mosaic Company (NYSE: MOS ... 2010 earnings results and financial tables on Tuesday, January ... New York Stock Exchange. Results will be available ... Company will host a conference call with presentation slides ... The call will begin at 11:00 a.m. Eastern ...
(Date:12/15/2009)... -- Thomson Reuters today ... the first drug pipeline database to fully integrate ... highly anticipated new content is being provided to ... ,, Thomson Pharma will offer drug ... releases, conferences, and other sources across all therapeutic ...
Breaking Biology Technology:Scientists Rediscover Gene Target for Cancer Therapy 2Scientists Rediscover Gene Target for Cancer Therapy 3Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 2Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 3Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 4Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 5Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 6Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 7Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 8Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 9Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 10Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 11Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 12Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 13Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 14Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 15Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 16Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 17Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 18Mosaic Announces Second Quarter Fiscal Year 2010 Earnings Release and Conference Call 2Thomson Reuters is First to Offer Fully Integrated Pipeline and Clinical Trials 2
... technology that could bring better, safer treatments to cancer patients ... Madison medical-device firm with more than 200 employees that has ... a year, its founder said. , ,The company is run ... into going commercial when GE Medical cut off its funding ...
... resident of Wisconsin and insert your card in an ATM ... bank, and your financial records. But if you find yourself ... to pay for an extensive series of tests because your ... hometown doctor's office. , ,Information technology baffles users with ever-growing ...
... in Milwaukee and the University of Wisconsin-Madison ... collaborative research opportunities and work together on tech transfer, ... medical schools' respective tech-transfer foundations are also in on ... Madison's Wisconsin Alumni Research Foundation plan to ...
Other Biology Technology:TomoTherapy considers IPO with medical-device business on the rise 2TomoTherapy considers IPO with medical-device business on the rise 3Physician mindset slows adoption of electronic health records 2Physician mindset slows adoption of electronic health records 3Physician mindset slows adoption of electronic health records 4
(Date:12/14/2009)... a novel antifreeze molecule in a freeze-tolerant Alaska beetle ... Unlike all previously described biological antifreezes that contain protein, ... protein. It is composed of a sugar and a ... the cells of organisms. , "The most exciting ... a whole new kind of antifreeze that may work ...
(Date:12/14/2009)... touching, or for Tasmanian devils biting each ... driven the dinosaurs to extinction through the transmission of ... f1000 Biology, highlights the ,paleobiological detective work, of David ... them to deduce that a protozoan parasite was to ... tyrannosaurid fossils. , The parasite,s modern-day equivalent, which infects ...
(Date:12/14/2009)... of the proteins in a species of salamander that ... similar regeneration could be induced in humans. , ... University Indianapolis and colleagues investigated over three hundred proteins ... salamander that has the unique natural ability to regenerate ... that this knowledge will contribute to a better understanding ...
Breaking Biology News(10 mins):Scientists isolate new antifreeze molecule in Alaska beetle 2IUPUI researchers tackle protein mechanisms behind limb regeneration 2Wisconsin Tobacco Tax Increase Is Positive Step for Health but Budget Disappoints by Cutting Funding for Tobacco Prevention Programs 50421 1Wisconsin Tobacco Tax Increase Is Positive Step for Health but Budget Disappoints by Cutting Funding for Tobacco Prevention Programs 50421 2Wisconsin Tobacco Tax Increase Is Positive Step for Health but Budget Disappoints by Cutting Funding for Tobacco Prevention Programs 50421 3Lupin Expands Branded Play 50416 1Lupin Expands Branded Play 50416 2Lupin Expands Branded Play 50416 3Bion Announces Approval of New U S Patent that Broadens Protection for the Companys Livestock Waste Environmental Treatment Processes 12848 1Bion Announces Approval of New U S Patent that Broadens Protection for the Companys Livestock Waste Environmental Treatment Processes 12848 2
... the University of Pennsylvania has completed a research study begun ... in the northwest Atlantic Ocean around Mount Desert Island, Me., ... shell during less than a century, providing a clear illustration ... study is published in the current issue of the ...
... previously believed are allergic to the most common fragrance ... presented at the Sahlgrenska Academy, University of Gothenburg, Sweden ... testing were allergic to the air oxidized form of ... about 2% of the complete population of Sweden are ...
... Medical Research Institute today announced that two researchers at ... nationwide to be appointed HHMI Early Career Scientists. ... the Center,s Basic Sciences Division, and Toshiyasu Taniguchi, M.D., ... and Public Health Sciences divisions, each will receive a ...
Other Biology News:Penn biologists demonstrate that size matters... in snail shells 2Penn biologists demonstrate that size matters... in snail shells 3Common fragrance ingredients in shampoos and conditioners are frequent causes of eczema 2Two Hutchinson Center researchers named HHMI Early Career Scientists 2
... White to off-white solid. A ... and blocks the formation of N-glycosidic ... against Gram-positive bacteria, yeasts, fungi, ... functional thrombin receptors on human T-lymphoblastoid ...
... 120 V, is used for agitation and mixing ... staining and destaining of gels and blots, and ... (8-40 rpm) and can handle a maximum load ... two 29 x 21 cm platforms covered with ...
Mouse monoclonal antibody to DCAMKL2 - doublecortin and CaM kinase-like 2...
...
Biology Products: